Hinge Health Inc. Class A Common Stock vs Modine Manufacturing Company — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Modine Manufacturing Company trades at $156.29 (market cap $9.17B). The key difference: Hinge Health Inc. Class A Common Stock and Modine Manufacturing Company are close in size by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Modine Manufacturing Company nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Modine Manufacturing Company for 33 Days on average.
| HNGE | MOD | |
|---|---|---|
Market Cap | $8.48B | $9.17B |
Volume | 879,799 | 1,397,357 |
Sector | Health | Industrials |
52-Week High | $105.14 | $283.95 |
52-Week Low | $31.17 | $110.73 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $8.10B | $9.60B |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Modine Manufacturing (MOD) trades at $172.57, showing minimal daily change. The stock exhibits a bearish technical signal with strong selling pressure on moving averages, though oscillators are neutral. Fundamentally, the company reported revenue of $2.58 billion in 2025 with a net income of $184 million, but profit margins are expected to compress in 2026. Recent corporate actions include the completion of a $946 million spin-off of its Performance Technologies unit with Gentherm, marking a strategic shift.
The outlook is mixed: strong analyst consensus with a $331.25 price target suggests significant upside, but near-term risks include margin pressure and bearish technical trends. Investment opportunity hinges on successful execution post-spin-off and data center cooling growth, while volatility from restructuring and market sentiment poses risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →